These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1021462)

  • 1. Serum immunoconglutinins and complement in systemic lupus erythematosus.
    Casali P; Scevola M
    Experientia; 1976 Dec; 32(12):1596-7. PubMed ID: 1021462
    [No Abstract]   [Full Text] [Related]  

  • 2. The significance of C3 and C4 complement levels in lupus nephritis.
    Levo Y; Pick AI
    Int Urol Nephrol; 1974; 6(3-4):233-8. PubMed ID: 4549215
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of serum concentration of C3 and C4 for the diagnosis, prognosis and treatment of SLE].
    Yasue T; Akutsu J; Shinjô H; Sasada K
    Nihon Hifuka Gakkai Zasshi; 1975 Dec; 85(14):875-83. PubMed ID: 1240511
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies of complement and its C3 and C4 component levels in patients with rheumatoid arthritis ans systemic lupus erythematosus].
    Brzezińska B; Bragiel I; Skowrońska H
    Pol Arch Med Wewn; 1976 Oct; 56(3):311-21. PubMed ID: 980923
    [No Abstract]   [Full Text] [Related]  

  • 6. [Components of the classical complement pathway in systemic lupus erythematosus].
    Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
    Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
    Lloyd W; Schur PH
    Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The terminal complement complex, C5b-9, a marker of disease activity in patients with systemic lupus erythematosus.
    Gawryl MS; Chudwin DS; Langlois PF; Lint TF
    Arthritis Rheum; 1988 Feb; 31(2):188-95. PubMed ID: 3348822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum-complement factors in the pseudo-LE syndrome (author's transl)].
    Kaboth U; Niederhut H; Brunner G
    Dtsch Med Wochenschr; 1977 Apr; 102(13):470-3. PubMed ID: 844426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complement system in disseminated lupus erythematosus].
    Vasquez JJ; Fontan G; Gil A; Barbado J; Alvarez I; Ojeda JA
    Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):725-31. PubMed ID: 76330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of C3 and C4 of serum complement in systemic lupus erythematosus (SLE)].
    Grlickov M
    God Zb Med Fak Skopje; 1978; 24():323-7. PubMed ID: 757182
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement deposition in the kidney.
    Berger J
    Adv Nephrol Necker Hosp; 1974; 4():37-48. PubMed ID: 4219998
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic lupus erythematosus in childhood correlations between changes in disease activity and serum complement levels.
    Singsen BH; Bernstein BH; King KK; Hanson V
    J Pediatr; 1976 Sep; 89(3):358-69. PubMed ID: 956959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of the study of complement in glomerulonephritis. Research on some serum complement fractions and their detection in renal biopsies with the use of microscopy and immunofluorescence].
    Martini PF; Camussi G; Segoloni G; Rotunno M; Triolo G; Mangiarotti G; Messina M; Caramello E
    Recenti Prog Med; 1978 Mar; 64(3):354-73. PubMed ID: 351753
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement activation in patients with systemic lupus erythematosus without nephritis.
    Mollnes TE; Haga HJ; Brun JG; Nielsen EW; Sjöholm A; Sturfeldt G; Mårtensson U; Bergh K; Rekvig OP
    Rheumatology (Oxford); 1999 Oct; 38(10):933-40. PubMed ID: 10534542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative value of serum C3 and C4 levels in predicting relapse in systemic lupus erythematosus.
    West CD
    Am J Kidney Dis; 1991 Dec; 18(6):686-8. PubMed ID: 1962654
    [No Abstract]   [Full Text] [Related]  

  • 18. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
    Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
    Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of complement components in systemic lupus erythematosus by radial immunodiffusion.
    Finberg R; Barland P; Grayzel AI
    Am J Clin Pathol; 1977 Jan; 67(1):97-9. PubMed ID: 401557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.